Floracia Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.30 M
as on 20-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 20-12-2024
- Revenue 42.10%
(FY 2022)
- Profit 46.06%
(FY 2022)
- Ebitda 48.97%
(FY 2022)
- Net Worth 33.15%
(FY 2022)
- Total Assets 29.60%
(FY 2022)
About Floracia Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.00 Cr.
Kalyan Deb, Ruhul Laskar, Rajib Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909DL2016PTC394933
- Company No.
017576
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Floracia Healthcare Private Limited offer?
Floracia Healthcare Private Limited offers a wide range of products and services, including Women Care, Women Care Supplements, Sexual Wellness, Sexual Health Supplements.
Who are the key members and board of directors at Floracia Healthcare?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Biplob Majumdar | Director | 12-Sep-2016 | Current |
Abdul Choudhury | Director | 12-Sep-2016 | Current |
Kalyan Deb | Director | 08-Oct-2016 | Current |
Ruhul Laskar | Director | 12-Sep-2016 | Current |
Rajib Gupta | Director | 12-Sep-2016 | Current |
Financial Performance of Floracia Healthcare.
Floracia Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.1% increase. The company also saw a substantial improvement in profitability, with a 46.06% increase in profit. The company's net worth Soared by an impressive increase of 33.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Floracia Healthcare?
In 2021, Floracia Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Floracia Pharmaceuticals Private LimitedActive 1 year 21 days
Ruhul Laskar, Rajib Gupta and 2 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 04 Oct 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Floracia Healthcare?
Floracia Healthcare has a workforce of 20 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Floracia Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Floracia Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.